Diagnosis and management of atypical parkinsonian syndromes.
Brooks
David J
DJ
Cyclotron Unit, Imperial College School of Medicine, Hammersmith Hospital, London UK. david.brooks@csc.mrc.ac.uk
D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D018680:Cholinergic Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D004599:Electric Stimulation Therapy; D006801:Humans; D009460:Neurologic Examination; D020734:Parkinsonian Disorders / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy
D000978:Antiparkinson Agents; D018680:Cholinergic Antagonists; D000547:Amantadine